drugset
drugset / Trial / NCT01607203

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

NCT01607203 ↗

Phase 4 Completed 120 enrolled AZ Jan Palfijn Gent Onze Lieve Vrouw Hospital · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.

Timeline

Start
2011-11
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triptorelin Other / unclassified 0.2 mg Subcutaneous
Comparator human chorionic gonadotropin Protein / enzyme biologic 5000 iu Subcutaneous

Indications

infertility disorder